Drug comparisons
Alogliptin vs Repaglinide
Alogliptin vs Repaglinide comparison for T2DM: DPP-4 inhibitor vs meglitinide. Efficacy, safety, side effects, and suitability for type 2 diabetes patients.
No comparison dimensions are available for this page.
Clinical context
Triggered when choosing an oral add-on after metformin for type 2 diabetes, comparing DPP-4 inhibitors to meglitinides for postprandial control.
Bottom line
Alogliptin generally offers a safer hypoglycemia profile than Repaglinide, but neither is superior for all patients.
All medication comparisons